Chief Medical Officer and Vice President of Regulatory Affairs Dr. Chulay brings broad medical and regulatory expertise to the Company. He joined AGTC in 2007 from AlphaVax, where as Senior Vice President and Chief Medical Officer he led successful clinical trial programs of recombinant viral vector vaccines for cytomegalovirus and influenza. Prior to joining AlphaVax, Dr. Chulay was a Principal Clinical Program Head in HIV and Opportunistic Infections at GlaxoSmithKline and was responsible for bringing two anti-infective drugs to market. He previously served as Chief of the Department of Immunology at the Walter Reed Army Institute of Research (WRAIR) and Chief of the Virology Division at the U.S. Army Research Institute of Infectious Disease (USAMRIID). Dr. Chulay earned a medical degree from Northwestern University Medical School and a degree in tropical medicine and hygiene from the London School of Hygiene and Tropical Medicine. He served his residency at Cleveland Metropolitan General Hospital and was a fellow in Infectious Disease at WRAIR. He has been a member of the Institute of Medicine Committee on Prevention and Control of Malaria, published 100 papers in peer-reviewed journals and is a reviewer for several leading medical journals.
